The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease
Open accessAbstract
This article gives a brief overview of the current understanding of the life cycle of the dopamine molecule, covering dopamine synthesis, storage, release, receptor and autoreceptor interactions, and reuptake. Special consideration is given to biochemical changes that occur in the nigrostriatal dopamine system in Parkinson's disease and how gene therapy may provide a new strategy for reversing parkinsonian biochemical deficits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Ehringer, H., & Hornykiewicz, O. (1960) · Klinische Wochenschrift · doi:10.1007/bf01485901 · Cited by 1,867
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Neurotransmitter Transporters: Recent Progress
Amara, S. G., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,082
Handbuch der Experimentellen Pharmakologie
(1939) · Springer eBooks · doi:10.1007/978-3-642-90793-7 · Cited by 966
Dopamine receptor pharmacology
Seeman, P., & Van Tol, H. H. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 956
THE OCCURRENCE, DISTRIBUTION AND PHYSIOLOGICAL ROLE OF CATECHOLAMINES IN THE NERVOUS SYSTEM
Carlsson, A. (1959) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07428-9 · Cited by 689
THE BIOCHEMISTRY OF PARKINSON'S DISEASE
Cookson, M. R. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133400 · Cited by 664
Compensations after lesions of central dopaminergic neurons: some clinical and basic implications
Zigmond, M. J., Abercrombie, E. D., Berger, T. W., Grace, A. A., & Stricker, E. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90112-n · Cited by 609
Catecholamine metabolism: basic aspects and clinical significance.
Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Molecular characterization of the dopamine transporter
Giros, B., & Caron, M. G. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90029-j · Cited by 562
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].
Birkmayer, W., & Hornykiewicz, O. (1961) · PubMed · Cited by 541
Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds
Tipton, K. F., & Singer, T. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13610.x · Cited by 539
Role of precursor availability in control of monoamine biosynthesis in brain.
Fernstrom, J. D. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.2.484 · Cited by 489
Storage and release of neurotransmitters
Kelly, R. B. (1993) · Cell · doi:10.1016/s0092-8674(05)80027-3 · Cited by 322
Rat brain phenolsulfotransferase—partial purification and some properties
Foldes, A., & Meek, J. L. (1973) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(73)90419-1 · Cited by 313
(1997) · Humana Press eBooks · doi:10.1007/978-1-4757-2635-0 · Cited by 257
Axelrod, J., & Weinshilboum, R. M. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208032870508 · Cited by 165
Dopamine receptor interactions: some implications for the treatment of Parkinson's disease
Robertson, H. A. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90034-6 · Cited by 154
Keefe, K. A., & Gerfen, C. R. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00024-d · Cited by 133
Hornykiewicz, O. (1993) · PubMed · Cited by 131
Biochemistry and Molecular Biology of the Vesicular Monoamine Transporter from Chromaffin Granules
Henry, J., Botton, D., Sagné, C., Isambert, M. F., Desnos, C., Blanchard, V., Raisman‐Vozari, R., Krejci, É., Massoulié, J., & Gasnier, B. (1994) · Journal of Experimental Biology · doi:10.1242/jeb.196.1.251 · Cited by 122
The transport of neurotransmitters into synaptic vesicles
Edwards, R. H. (1992) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(92)90023-e · Cited by 122
The nigrostriatal system in Parkinson's disease.
Graybiel, A. M., Hirsch, É. C., & Agid, Y. (1990) · PubMed · Cited by 113
New insights into dopamine receptors in the central nervous system
Strange, P. G. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90050-f · Cited by 106
Catecholamine synthesis: Physiological coupling to precursor supply
Milner, J. D., & Wurtman, R. J. (1986) · Biochemical Pharmacology · doi:10.1016/0006-2952(86)90071-7 · Cited by 102
Mogi, M., Harada, M., Kiuchi, K., Kojima, K., Kondo, T., Narabayashi, H., Rausch, D., Riederer, P., Jellinger, K., & Nagatsu, T. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244634 · Cited by 101
Molecular, Functional and Biochemical Characteristics of the Dopamine Transporter
Hitri, A., Hurd, Y. L., Wyatt, R. J., & Deutsch, S. I. (1994) · Clinical Neuropharmacology · doi:10.1097/00002826-199402000-00001 · Cited by 94
Differential expression of autoreceptors in the ascending dopamine systems of the human brain.
Meador‐Woodruff, J. H., Damask, S. P., & Watson, S. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8297 · Cited by 84
Hurd, Y. L., Pristupa, Z. B., Herman, M. M., Niznik, H. B., & Kleinman, J. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90535-5 · Cited by 81
Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile
González, A. M., Walther, D. M., Pazos, Á., & Uhl, G. R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90050-7 · Cited by 74
The enigma of neuromelanin in Parkinson's disease substantia nigra.
Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1994) · PubMed · Cited by 70
N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
Naoi, M., Dostert, P., Yoshida, M., & NAGATSU, T. (1993) · PubMed · Cited by 54
Sandler, M. (1972) · Springer eBooks · doi:10.1007/978-3-642-65249-3_19 · Cited by 25
Kainic acid lesion of the striatum increases dopamine release but reduces 3-methoxytyramine level
Naudon, L., Dourmap, N., Leroux‐Nicollet, I., & Costentin, J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90477-q · Cited by 24
Chapter 26 The transport of neurotransmitters into synaptic vesicles
Peter, D., Liu, Y., Brecha, N. C., & Edwards, R. H. (1995) · Progress in brain research · doi:10.1016/s0079-6123(08)63304-x · Cited by 10
Cited by
Friggi‐Grelin, F., Coulom, H., Meller, M., Gomez, D., Hirsh, J., & Birman, S. (2003) · Journal of Neurobiology · doi:10.1002/neu.10185 · Cited by 550
Calderón‐Ospina, C. A., & Nava‐Mesa, M. O. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13207 · Cited by 530
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Zhang, A., Neumeyer, J. L., & Baldessarini, R. J. (2007) · Chemical Reviews · doi:10.1021/cr050263h · Cited by 428
Comparison of in vitro antioxidant and antiradical activities of L-tyrosine and L-Dopa
Gülçin, İ. (2007) · Amino Acids · doi:10.1007/s00726-006-0379-x · Cited by 357
Metadata
- Authors
- Elsworth, J. D., & Roth, R. H.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 1997-03
- Volume
- 144
- Issue
- 1
- Pages
- 4-9
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2013734734
- Cited by
- 285
- References
- 37
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.